Latest News
Private equity firm JZ Capital Partners Limited (JZCP) has closed a co-investment alongside an investor group led by Orangewood Partners in K2 Towers (K2), an operator and owner of wireless communication towers.
JZCP invested USD22 million in K2 which was founded in 2009 and specialises in acquiring and maintaining wireless communication towers. K2’s existing portfolio stretches throughout the United States and Puerto Rico.
David Zalaznick, JZCP’s Founder and Investment Adviser, says: “This transaction expands our US portfolio of diverse, high quality companies. We are confident in the growth prospects of K2 and the specialist sector in which it operates and
Equity and bond markets experienced renewed tensions during the period under review. European markets saw higher selling pressure than US markets, which was a negative for Global Macro managers as they have sizeable long European equities positions in their portfolios.
IK Investment Partners (IK) has received a binding offer from International Flavors & Fragrances Inc. (NYSE:IFF) (“IFF”), a leading global creator of flavours and fragrances for consumer products, for the sale of Lucas Meyer Cosmetics group of companies.
The transaction is structured as an exclusive binding offer in order to allow Unipex Group to consult with its French works council prior to entering into the final agreement. The transaction is expected to close in the third quarter of 2015 and is subject to exclusivity protection. Under the terms of the offer IFF will pay approximately EUR283 million.
Under IK’s
During its fiscal year that will end on 30 June, 2015, BioAdvance’s life sciences portfolio companies attracted USD85 million of capital from private investments and other sources.
“It’s been another strong year for our portfolio companies” says Barbara Schilberg CEO of BioAdvance. “While several companies have raised significant amounts of venture capital others have received non-dilutive funding achieved product sales secured development contracts accessed the public markets or progressed products through collaborations with larger companies. This progress confirms that there are multiple paths to success for life sciences companies.”
Galleon Pharmaceuticals raised USD10 million in a Series B round supplemented
Returns offered by the private equity asset class are often a hot topic for discussion in the investment industry. With yields varying between fund types, sectors and managers, Jessica Duong (pictured) investigates the differences in performance of sector-specific buyout funds in this extract from Preqin Private Equity Spotlight – June 2015.
One of the main attractions of private equity for investors is the potential for outperformance over public equities over the longer term and the prospect of high yields. Offering insight into the sentiment of the LP community, Preqin’s latest global study of LPs revealed that 37 per cent of
BlackRock is to acquire Infraestructura Institucional, Mexico’s leading independently managed, infrastructure investment firm, expanding BlackRock’s infrastructure capabilities in Mexico.
The agreement builds upon BlackRock’s existing USD6 billion global infrastructure platform and strengthens the Firm’s long-standing Mexico business. The acquisition will fully enable BlackRock to deliver to its local and international clients the compelling infrastructure opportunities emerging in Mexico. Upon closing, BlackRock’s infrastructure investment platform will manage more than USD7 billion of invested and committed assets and over 80 employees located in six offices globally. The Firm’s Mexico office will grow to over 50 employees and USD26 billion of assets under
Nordic Capital Fund VII (Nordic Capital) has expanded its holdings in the child safety market with an investment in Max-Inf, manufacturer of children’s car seats based in China.
The transaction allows Britax and Max-Inf to further develop their relationship and accelerate growth in the key Asian markets.
Max-Inf is headquartered in Ningbo, China. In 2014 the company had revenues of approximately USD 73mn and over 700 employees. The company manufactures child restraint systems, some of which are exported and some marketed in China under its own brand Baby First.
“Max-Inf has been our exclusive distributor for Britax products in China
Salient Partners has successfully completed its acquisition of Forward Management, creating a USD27 billion diversified asset management firm and reaffirming the firm’s position as provider of liquid alternative and real asset investment strategies.
The combined firm has 250 employees across its offices in Houston, San Francisco and New York.
Salient's management team will continue to be led by John Blaisdell as chairman and chief executive officer, along with Jeremy Radcliffe as president, Lee Partridge as chief investment officer, Ben Hunt as chief risk officer, and Robert Naka as chief operating officer. The firm's portfolio management teams report to Lee
Shoreline Capital, a private fund manager in Chinese distressed debt and special situation investments, has closed its third fund at USUSD500 million. The fund, Shoreline China Value III, was over-subscribed.
Meanwhile, Shoreline held the first close for Fund IIIs overflow fund at USD115 million. Based on current indications of interest, Shoreline expects the overflow fund to also be oversubscribed within the month.
Since the firms inception in 2004, Shoreline has focused on illiquid credit-related opportunities arising from the inefficiencies in China’s financial system. Such opportunities include (i) non-performing loan (NPL) portfolios; (ii) distressed special situations; and (iii) non-distressed special situation investments.
Maranon Capital has appointed Daniel Kirmse and Santo Barretta as Portfolio Analysts while Fiona O’Connor has joined the firm as an Executive Assistant.
Kirmse was previously a Commercial Banking Representative with MB Financial Bank where he was responsible for investment underwriting and portfolio management. He earned both a BS and a MS in Accountancy from the University of Illinois at Urbana-Champaign and is a non-practicing CPA.
Barretta joins Maranon from Standard & Poor’s where he was a Research Analyst in the US Not-For-Profit Health Care group. Santo earned his BBA in Finance from Hofstra University and is currently a 2015
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
